Good Day BIO Newsletter Archive | May 4, 2023
Exciting news from BIO members today, as the FDA has approved the first RSV vaccine in the U.S. for older adults, and Eli Lilly has promising news about its Alzheimer’s drug. Meanwhile, a new analysis asks: who will pay for transformative therapies? (640 words, 3 minutes, 12 seconds)